IP Library › Granted Patent US 12,321,043
Granted Patent B2
US 12,321,043 · App. 17/776,780 · Granted Jun 3, 2025

Soft contact lens and a packaging comprising such a soft contact lens

Inventor: Alessandro Filippo (Puntarenas, CR)
G02C7/04G02B1/043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,321,043
App. No.
17/776,780
Granted
Jun 3, 2025
Kind
B2
Abstract

A soft contact lens ( 4 ) comprises a solid component, which is based on a polymer, and a liquid component which is distributed in the solid component and which comprises at least one compound which is selected from vitamin E, vitamin B2 and the respective derivatives thereof. The contact lens has a degree of transmission of type A ultraviolet radiation greater than 50% and a degree of transmission of type B ultraviolet radiation greater than 20%.

Claims (29)

1. A soft contact lens ( 4 ) comprising:

a solid component, which is based on a polymer, and which is provided to confer shape and structure on the soft contact lens, and

a liquid component which is distributed in the solid component, wherein:

the soft contact lens has a degree of transmission of type A ultraviolet radiation greater than 90%,

the soft contact lens has a degree of transmission of type B ultraviolet radiation greater than 90%, and

the liquid component comprises at least one compound which is selected from the group consisting of: vitamin E, vitamin B2, and respective derivatives thereof.

2. The soft contact lens according to claim 1 , wherein the vitamin E is α-tocopherol.

3. The soft contact lens according to claim 1 , wherein the vitamin E is an α-tocopherol which is functionalized with polyethylene glycol succinate (TPGS).

4. The soft contact lens according to claim 1 , wherein the concentration of the vitamin E or a derivative thereof in the liquid component is between 0.0001% and 2%.

5. The soft contact lens according to claim 1 , wherein the concentration of the vitamin B2 or a derivative thereof in the liquid component is between 0.001% and 0.2%.

6. The soft contact lens according to claim 1 , wherein the liquid component comprises a quantity of compounds which regulate the rheological properties and which are selected from the group consisting of: hyaluronic acid, derivatives thereof and a polysaccharide.

7. The soft contact lens according to claim 6 , wherein the polysaccharide is galactoxyloglucan extracted from tamarind seeds (TSP).

8. The soft contact lens according to claim 1 , wherein the concentration of the vitamin E or a derivative thereof in the liquid component is between 0.01% and 1.5%.

9. The soft contact lens according to claim 1 , wherein the concentration of the vitamin E or a derivative thereof in the liquid component is between 0.1% and 1%.

10. The soft contact lens according to claim 1 , wherein the concentration of the vitamin B2 or a derivative thereof in the liquid component is between 0.01% and 0.1%.

11. A packaging ( 1 ) comprising:

a soft contact lens ( 4 ) which is immersed in a preservation solution ( 5 ), the soft contact lens comprising:

a solid component, which is based on a polymer, and which is provided to confer shape and structure on the soft contact lens; and

a liquid component which is distributed in the solid component, the liquid component comprises at least one compound which is selected from the group consisting of: vitamin E, vitamin B2, and respective derivatives thereof;

wherein the soft contact lens has a degree of transmission of type A ultraviolet radiation greater than 50%, and the soft contact lens has a degree of transmission of type B ultraviolet radiation greater than 20%; and

wherein the preservation solution ( 5 ) comprises at least one compound of the group at a concentration which is at least equal to the one present in the liquid component of the soft contact lens.

12. The packaging according to claim 11 , wherein the soft contact lens has a degree of transmission of type A ultraviolet radiation greater than 70% and a degree of transmission of type B ultraviolet radiation greater than 50%.

13. The packaging according to claim 12 , wherein the soft contact lens has a degree of transmission of type A and type B ultraviolet radiation greater than 90%.

14. The packaging according to claim 11 , wherein the vitamin E is α-tocopherol.

15. The packaging according to claim 11 , wherein the vitamin E is an α-tocopherol which is functionalized with polyethylene glycol succinate (TPGS).

16. The packaging according to claim 11 , wherein the concentration of the vitamin E or a derivative thereof in the liquid component is between 0.0001% and 2%.

17. The packaging according to claim 11 , wherein the concentration of the vitamin B2 or a derivative thereof in the liquid component is between 0.001% and 0.2%.

18. The packaging according to claim 11 , wherein the liquid component comprises a quantity of compounds which regulate the rheological properties and which are selected from the group consisting of: hyaluronic acid, derivatives thereof and a polysaccharide.

19. The packaging according to claim 18 , wherein the polysaccharide is galactoxyloglucan extracted from tamarind seeds (TSP).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2025
From: BF RESEARCH S.R.L.
To: CATALTHEIA GROUP, INC.
Reel/Frame 070602/0894 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: FILIPPO, ALESSANDRO
To: BF RESEARCH S.R.L.
Reel/Frame 068552/0448 →
Priority Claims (1)
IT 102019000021849 · Nov 21, 2019 · national
Continuity (1)
Related Publication 20220390762A1 · Dec 8, 2022
References Cited (28)
US 8784867B2 · Samuel · 2014 [cited by examiner]
US 20060073184A1 · Xia et al. · 2006 [cited by applicant]
US 20130178518A1 · Samuel · 2013 [cited by examiner]
US 20170351115A1 · Filippo · 2017 [cited by applicant]
US 20200054555A1 · Rout et al. · 2020 [cited by applicant]
CN 108853116A · 2018 [cited by applicant]
CN 109828384A · 2019 [cited by applicant]
CN 107260655B · 2021 [cited by applicant]
EP 2103552A1 · 2009 [cited by applicant]
JP 2005502392A · 2005 [cited by applicant]
JP 2005084558A · 2005 [cited by applicant]
JP 2006039529A · 2006 [cited by applicant]
JP 2013500302A · 2013 [cited by applicant]
JP 2015507649A · 2015 [cited by applicant]
JP 2015509205A · 2015 [cited by applicant]
JP 2015230398A · 2015 [cited by applicant]
JP 2019504168A · 2019 [cited by applicant]
JP 2019509516A · 2019 [cited by applicant]
KR 100741610B1 · 2007 [cited by applicant]
WO 2006085351A1 · 2006 [cited by applicant]
WO 2009154169A1 · 2009 [cited by applicant]
WO 2013086077A1 · 2013 [cited by applicant]
WO 2015186723A1 · 2015 [cited by applicant]
WO 2017090128A1 · 2017 [cited by applicant]
WO 2017131588A1 · 2017 [cited by applicant]
WO 2018172511A1 · 2018 [cited by applicant]
Peng, C. C., Kim, J., & Chauhan, A. (2010). Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials, 31(14), 4032-4047. https://doi.org/10.1016/… [cited by applicant]
Decision of Refusal for corresponding Japanese Application No. 2022-529625 dated Dec. 24, 2024, 5 pages long. [cited by applicant]